<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: We investigated the prognostic implication of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> according to modified National Cholesterol Education Program criteria and the implication of individual features of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> on <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and CHD in a 5-year community-based study of people with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We entered 562 participants, aged 30-74 years, into a cross-sectional analysis and 428 participants (comprising those who were <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-free at study entry) into a prospective analysis </plain></SENT>
<SENT sid="2" pm="."><plain>In both analyses, the association of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> features with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>/CHD was studied </plain></SENT>
<SENT sid="3" pm="."><plain>Binary logistic regression, a Cox regression model and Fisher's exact test were used for statistical analyses </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: At diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was independently associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (odds ratio [OR] 2.54; p=0.006) and CHD (OR 4.06; p=0.002) </plain></SENT>
<SENT sid="5" pm="."><plain>In the 5-year follow-up, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> at baseline was an independent predictor of incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (hazard ratio [HR] 2.05; p=0.019) </plain></SENT>
<SENT sid="6" pm="."><plain>An increase in the number of individual features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> present at the time of diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was associated with a linear increase in incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk (trend p=0.044) with an almost five-fold increase when <z:hpo ids='HP_0000001'>all</z:hpo> five features were present, compared with <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> alone (HR 4.76; p=0.042) </plain></SENT>
<SENT sid="7" pm="."><plain>Increasing age (HR 1.07; p&lt;0.001), female sex (HR 0.62; p=0.032), total cholesterol (HR 1.43; p=0.01) and <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering therapy (HR 0.32; p&lt;0.001) were also independent predictors of risk </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> at baseline is associated with an increased risk of incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in the 5 years following diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-free survival rates declined incrementally as the presence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> features increased </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, identifying the features of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> at diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is potentially a useful prognostic tool for identifying individuals at increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>